In summary, these data support a working model where, across disease states such as cancer, fibrosis, and chronic inflammation, S100A4 regulates pathogenic macrophage polarization to an M2-like, alternatively activated state with immunosuppressive and profibrotic functions. The gene discussed is S100A4; the disease is cancer.